Prudence A. Francis

1993–2026 年に発表

別表記
Prudence A Francis
81
論文数
19,314
被引用数
55
h 指数
78
i10 指数

被引用数

Prudence A. Francis の年別被引用数1971 年: 被引用 1 件1993 年: 被引用 2 件1995 年: 被引用 8 件1996 年: 被引用 12 件1997 年: 被引用 16 件1998 年: 被引用 30 件1999 年: 被引用 13 件2000 年: 被引用 19 件2001 年: 被引用 18 件2002 年: 被引用 19 件2003 年: 被引用 19 件2004 年: 被引用 7 件2005 年: 被引用 5 件2006 年: 被引用 10 件2007 年: 被引用 5 件2008 年: 被引用 5 件2009 年: 被引用 20 件2010 年: 被引用 21 件2011 年: 被引用 12 件2012 年: 被引用 23 件2013 年: 被引用 41 件2014 年: 被引用 81 件2015 年: 被引用 156 件2016 年: 被引用 172 件2017 年: 被引用 176 件2018 年: 被引用 181 件2019 年: 被引用 644 件2020 年: 被引用 757 件2021 年: 被引用 844 件2022 年: 被引用 694 件2023 年: 被引用 607 件2024 年: 被引用 1,029 件2025 年: 被引用 481 件2026 年: 被引用 19 件1972〜1992 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,699 件、この内訳の 16.9%中国: 引用元論文 848 件、この内訳の 8.4%イタリア: 引用元論文 754 件、この内訳の 7.5%イギリス: 引用元論文 521 件、この内訳の 5.2%ドイツ: 引用元論文 491 件、この内訳の 4.9%フランス: 引用元論文 474 件、この内訳の 4.7%オーストラリア: 引用元論文 415 件、この内訳の 4.1%スペイン: 引用元論文 401 件、この内訳の 4%ベルギー: 引用元論文 395 件、この内訳の 3.9%カナダ: 引用元論文 340 件、この内訳の 3.4%スイス: 引用元論文 321 件、この内訳の 3.2%日本: 引用元論文 296 件、この内訳の 3%
0%16.9%その他 30.8%

分野

  • Medicine60.4%
  • Biochemistry, Genetics and Molecular Biology30.8%
  • Immunology and Microbiology2.5%
  • Computer Science1.7%
  • Engineering1.3%
  • Materials Science0.8%
  • その他2.5%

トピック

  • Breast Cancer Treatment Studies10.2%
  • Advanced Breast Cancer Therapies6.8%
  • Cancer Immunotherapy and Biomarkers6.2%
  • HER2/EGFR in Cancer Research5.1%
  • Cancer Treatment and Pharmacology3.2%
  • Immunotherapy and Immune Responses2.8%
  • その他65.7%

共著者

全論文

検索で開く
  1. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph A. Sparano, Tanja Španić, Sandra M. Swain, Sergei Tjulandin, Masakazu Toi, Dario Trapani, Andrew Tutt, B. Xu, Giuseppe Curigliano, Nadia Harbeck - Annals of Oncology 2023 被引用: 844

  2. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvia P. Neciosup, B.V. Offersen, Shinji Ohno, Olivia Pagani, A. Prat, Frédérique Penault‐Llorca, Hope S. Rugo, G. W. Sledge, Christoph Thomssen, D.A. Vorobiof, Theresa Wiseman, Binghe Xu, Larry Norton, A. Costa, Eric P. Winer - Annals of Oncology 2020 被引用: 1,356

  3. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer - Annals of Oncology 2016 被引用: 2,062

  4. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 被引用: 803

  5. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 891

  6. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 1,647

  7. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 被引用: 299

  8. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista ほか 454 名 - npj Breast Cancer 2021 被引用: 275

  9. openalex_id:w4226348827

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, R. Jakesz, Christian Fesl, Olivia Pagani, Richard D. Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy S. Albain, Stewart Anderson, R. Arriagada, John M.S. Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa A. Carey, Robert E. Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain 被引用: 223

  10. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Curigliano, Jana de Boniface, Suzette Delaloge, A. DeMichele, Carsten Denkert, Gerd Fastner, Florian Fitzal, Prudence A. Francis, H Gamal, Oreste ­Gentilini, Michael Gnant, William J. Gradishar, B. Gulluoglu, Nadia Harbeck, Jörg Heil, Chien Shiun Huang, Jens Huober, Zeping Jiang, Orit Kaidar‐Person, Marleen Kok, Eun‐So Lee, Sherene Loi, S. Loibl, Miguel Martín, Icro Meattini, Monica Morrow, A. H. Partridge, Frédérique Penault‐Llorca, Martine Piccart, Lori J. Pierce, Philip Poortmans, Meredith M. Regan, J. S. Reis-Filho, Isabel T. Rubio, Hope S. Rugo, Emiel J. Rutgers, Cristina Saura, Elżbieta Senkus, Zhi-Ming Shao, Christian F. Singer, Tanja Španič, Beat Thuerlimann, Masakazu Toi, Sara M. Tolaney, Nicholas C. Turner, Andrew Tutt, M.-J. Vrancken Peeters, Toru Watanabe, William P. Weber, Hans Wildiers, B. Xu - Annals of Oncology 2023 被引用: 221

  11. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 被引用: 1,255

  12. The Lancet Breast Cancer Commission

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dingle Spence, Hilary Stobart, Valentina Vargas Enciso, Inês Vaz-Luís, Cynthia Villarreal‐Garza, Héctor Arreola‐Ornelas, Afsan Bhadelia, Judy C. Boughey, Sanjoy Chatterjee, David Dodwell, Svetlana V. Doubova, Dorothy Du Plooy, Beverley M. Essue, Neha Goel, Julie R. Gralow, Sarah T. Hawley, Belinda E. Kiely, Ritse M. Mann, Shirley Mertz, Carlo Palmieri, Philip Poortmans, Tanja Španić, Lesley Stephen, Fraser Symmans, Catherine Towns, Didier Verhoeven, Sarah Vinnicombe, David Watkins, Cheng Har Yip, Brian J. Zikmund‐Fisher - The Lancet 2024 被引用: 154

  13. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 被引用: 673

  14. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 154

  15. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Belinda E. Kiely, Sungbae Kim, Smruti Koppikar, Marion Kuper‐Hommel, Frédéric Lecouvet, Ginny Mason, Shirley Mertz, Volkmar Müller, Claire Myerson, Silvia P. Neciosup, Birgitte Vrou Offersen, Shinji Ohno, Olivia Pagani, Ann H. Partridge, Frédérique Penault‐Llorca, Aleix Prat, Hope S. Rugo, Elżbieta Senkus, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Daniel Vorobiof, Peter Vuylsteke, Theresa Wiseman, Binghe Xu, Alberto Costa, Larry Norton, Eric P. Winer - The Breast 2024 被引用: 197

  16. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 被引用: 747

  17. Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - npj Breast Cancer 2022 被引用: 78

  18. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 727

  19. Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study

    著者: , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 被引用: 55

  20. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 542

  21. Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 150

  22. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 58

  23. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 148

  24. Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 60